Min Sil Kang

3PUBLICATIONS
4CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 09, 2024
Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Enhances Natural Killer Cell Cytotoxicity in HER2-Overexpressing Ovarian Cancer.

Sa Deok Hong, Nar Bahadur Katuwal, Min Sil Kang

|Dec 09, 2023
PSPC1 Inhibition Synergizes with Poly(ADP-ribose) Polymerase Inhibitors in a Preclinical Model of BRCA-Mutated Breast/Ovarian Cancer.

Mithun Ghosh, Min Sil Kang, Nar Bahadur Katuwal

|Oct 14, 2023
Combined PI3K Inhibitor and Eribulin Enhances Anti-Tumor Activity in Preclinical Models of Paclitaxel-Resistant, PIK3CA-Mutated Endometrial Cancer.

Yeong Gyu Jeong, Nar Bahadur Katuwal, Min Sil Kang

Pageof 1

Frequent Collaborators

3 joint publications

Nar Bahadur Katuwal

3 joint publications

Yong Wha Moon

1 joint publications

Sa Deok Hong

1 joint publications

Seung Ryeol Lee